- Home
- VITL vs BHVN Comparison
VITL vs BHVN Comparison
Compare VITL & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VITL | BHVN |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VITL | BHVN |
|---|---|---|
| Price | $27.59 | $11.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $48.56 | $30.36 |
| AVG Volume (30 Days) | 1.6M | ★ 2.6M |
| Earning Date | 02-26-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.60 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $711,881,000.00 | N/A |
| Revenue This Year | $27.92 | N/A |
| Revenue Next Year | $23.45 | N/A |
| P/E Ratio | $19.52 | ★ N/A |
| Revenue Growth | ★ 23.56 | N/A |
| 52 Week Low | $25.51 | $7.48 |
| 52 Week High | $53.13 | $44.28 |
Technical Indicators
Market Signals| Indicator | VITL | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 45.74 | 48.00 |
| Support Level | $25.51 | $11.35 |
| Resistance Level | $27.22 | $13.08 |
| Average True Range (ATR) | 1.35 | 0.78 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 54.17 | 33.15 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.